Kate Haviland, CEO: Blueprint Medicines BPMC Sell · Filed 25/03/07

Trade details

Type: Insider sale
Amount: $1,434,208.8
Shares · price: 16,151 sh · $88.80 a share
Held after: 168,427 sh
Stock: Blueprint Medicines BPMC
Person: Kate HavilandCEO
Trade date: 25/03/05
Filed: 25/03/07
Days to filing: 2 days

Sold 8.8% of holdings

Share of holding sold: 8.8%

Blueprint Medicines trades, last 26 weeks

What else happened in Blueprint Medicines around then

Filed or reported within 30 days of the trade day · 25/02/03~25/04/04

Kate Haviland's recent trades

Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$104.8K
1,200 sh
$104.8K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$51.5K
598 sh
$51.5K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$51.3K
600 sh
$51.3K
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$8,859
100 sh
$8,859
Filed 25/04/03
Traded 25/04/01
Kate HavilandCEO
Sell10b5-1 planBlueprint Medicines
Sell10b5-1 plan
Blueprint Medicines
BPMC
$159.4K
1,446 sh
$159.4K
Filed 25/01/23
Traded 25/01/21